Companies dominating the Global Computational Biology Landscape
- Dassault Systèmes SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Certara Inc.
- Instem Group
- Compugen
- Chemical Computing Group ULC
- Rhenovia Pharma SAS
- Nimbus Discovery LLC
- Rhenovia Pharma SAS
- Insilico Biotechnology AG
- Genedata AG
Browse Key Market Insights with Data Illustration:
In the News
Certara Inc. announced that the U.S. Food and Drug Administration (FDA) has renewed and expanded the company’s licenses of Certra’s proprietarybiosimulation software along with other 400 user licenses of Phoenix software and Simcyp.
Instem Group declared the acquisition of Edge Software Consultancy Ltd to expand its portfolio to discover R&D activities thereby bringing the client products into the market at a faster rate. The technology and services of the Edge helped to enhance the research and development activities of drug discovery and increased client productivity.
